or
forgot password
  • cancer clinical trials in ann arbor, MI

  • Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Kidney Cancer
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Childhood Cancer Survivor Study
    University of Michigan/Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Cancer
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Breast Cancer
    Validation of a Multi-gene Test for Lung Cancer Risk
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Lung Cancer
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    A Multicenter, Open-label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Male or Female Patients With a Serious or Immediately Life-threatening, Disease or Condition Caused by CMV, ADV, HSV, VAVC, VARV or, Monkeypox Viruses(s) Who Have a Life Expectancy of ≥ 2 Weeks and for, Whom no Comparable or Satisfactory Alternative Therapy is Available
    Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Iris Melanoma, Metastatic Intraocular Melanoma, Recurrent Intraocular Melanoma
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    University of Michigan Comprehensive Cancer Center

    Trial Locations
    University of Michigan Comprehensive Cancer Center
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Colorectal Cancer
    Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    End Stage Renal Disease, Renal Transplant
    Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Head and Neck Cancer, Mucositis, Oral Complications of Radiation Therapy, Pain
    Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Kidney Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 in Castration-Resistant Prostate Cancer (CRPC)
    University of Michigan Health System
    Ann Arbor, Michigan
    Prostate Cancer
    A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Estrogen Receptor Negative (ER-Negative) Breast Cancer, Progesterone Receptor Negative (PR-Negative) Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer, Brain Metastases
    Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Acute Myeloid Leukemia
    Natural History Study of SCID Disorders
    University of Michigan Health System
    Ann Arbor, Michigan
    SCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis, ADA Deficiency, XSCID
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    C S Mott Children's Hospital
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Leukemia, Acute Myeloid Leukemia, Acute Nonlymphocytic Leukemia
    Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic Cancer
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    University of Michigan University Hospital
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Breast Cancer
    Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
    University of Michigan, Comprehensive Cancer Center
    Ann Arbor, Michigan 48109
    Diffuse Large B-cell Lymphoma
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    PONATINIB for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)
    University of Michigan Medical Center, Site # 011
    Ann Arbor, Michigan 48109
    Chronic Myeloid Leukemia (CML), Ph+ Acute Lymphoblastic Leukemia (ALL)
    Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Recurrent Thyroid Cancer, Stage I Follicular Thyroid Cancer, Stage I Papillary Thyroid Cancer, Stage II Follicular Thyroid Cancer, Stage II Papillary Thyroid Cancer, Stage III Follicular Thyroid Cancer, Stage III Papillary Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer, Stage IVB Follicular Thyroid Cancer, Stage IVB Papillary Thyroid Cancer, Stage IVC Follicular Thyroid Cancer, Stage IVC Papillary Thyroid Cancer
    Nephrotic Syndrome Study Network
    University of Michigan Medical Center

    Trial Locations
    University of Michigan Medical Center
    CS Mott Children's Hospital, University of Michigan
    Minimal Change Disease (MCD), Membranous Nephropathy, Glomerulosclerosis, Focal Segmental
    Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma
    A. Alfred Taubman Health Care Center
    Ann Arbor, Michigan 48109
    Hepatocellular Carcinoma